市場調查報告書
商品編碼
1361125
切向流過濾市場規模- 按產品類型(系統{拋棄式、可重複使用}、膜、配件)、技術(微濾)、應用(蛋白質純化)、最終用途(製藥和生物技術公司)、全球預測,2023 年 - 2032Tangential Flow Filtration Market Size - By Product Type (Systems {Single-use, Reusable}, Membrane, Accessories), Technology (Microfiltration), Application (Protein Purification), End-use (Pharma & Biotech Companies), Global Forecast, 2023 - 2032 |
2023 年至 2032 年間,全球切向流過濾市場的年複合成長率將達到 11.8%。生物製藥行業不斷擴大的足跡需要高效且可擴展的純化方法,而 TFF 可以提供高生產率和產量。對精準醫療和生物技術應用的日益關注推動了生物分子分離和濃縮領域對 TFF 的需求。此外,出於環境考慮,TFF 在水處理和食品加工中被採用。總體而言,切向流過濾市場的成長是由其多功能性、成本效益以及在關鍵產業中的關鍵角色所推動的。
領先企業的不斷擴張的行業擴張支持了市場成長。例如,2023 年 9 月,專門從事下游應用的著名生物加工技術公司 Verdot 推出了 FlexiPro TFF。這種符合 GMP 的多用途切向流過濾 (TFF) 系統滿足了市場對基因治療、疫苗和基於 mRNA 的治療產品日益成長的需求。該系統的開發借鑒了 Verdot 廣泛的研發專業知識,這些專業知識源自於其先前在設計、製造和測試客製化不銹鋼 TFF 撬裝裝置方面的工作。
整個切向流過濾市場根據產品類型、最終用途和地區進行分類。
薄膜過濾器領域將在 2023 年至 2032 年間經歷重大發展。薄膜過濾器在 TFF 系統中發揮關鍵作用,促進生物分子的分離和濃縮。這項需求是由生物製藥、生物技術和環境領域不斷擴大的應用所推動的。隨著薄膜過濾器正在成為確保高效、精確的生物分子處理的關鍵因素,它們對切向流過濾市場規模的貢獻不斷成長。
合約研究組織和合約製造組織部門從 2023 年到 2032 年將實現令人稱讚的年複合成長率。這些實體需要高效且通用的純化方法來進行生物製藥生產和研究。 TFF 精確分離和濃縮生物分子的能力使其在這些領域不可或缺,符合他們對高品質、可擴展製程的需求。這種不斷成長的需求證明了 TFF 在支持生物製藥行業不斷擴大的外包需求方面的重要性。
歐洲切向流過濾市場從 2023 年到 2032 年將呈現可觀的年複合成長率。這一成長歸因於該地區強勁的生物製藥行業以及對生物技術研究和生產的日益重視。
例如,2023 年9 月,根據倫敦大學研究人員的見解,用於細胞轉染以誘導基因表現的慢病毒載體(LV) 表現出卓越的能力,能夠承受兩倍於正常值的剪切速率,同時保持同等的生產力水準。在評估滲濾期間的剪切力時,科學家採用了切向流過濾 (TFF) 的超縮小 (USD) 模擬。 TFF 提高流程效率和產品品質的能力使其成為這些領域的重要組成部分。隨著歐洲仍處於創新生物製藥和生物技術發展的前沿,其採用率持續成長。
Global Tangential Flow Filtration Market will witness 11.8% CAGR between 2023 and 2032. The biopharmaceutical industry's expanding footprint demands efficient and scalable purification methods, with TFF offering high productivity and yield. The increasing focus on precision medicine and biotechnology applications fuels the demand for TFF in the separation and concentration of biomolecules. Additionally, environmental concerns have led to the adoption of TFF in water treatment and food processing. Overall, the tangential flow filtration market growth is driven by its versatility, cost-effectiveness, and crucial role in critical industries.
The rising industry expansion by leading companies supports market growth. For instance, in September 2023, Verdot, a prominent bioprocessing technology firm specializing in downstream applications, introduced the FlexiPro TFF. This GMP-compliant, multipurpose tangential flow filtration (TFF) system responds to the increasing market need for gene therapy, vaccines, and mRNA-based therapeutic products. The development of this system draws from Verdot's extensive research and development expertise, derived from its prior work in designing, manufacturing, and testing custom stainless-steel TFF skid units.
The overall Tangential Flow Filtration Market is classified based on product type, end-use, and region.
The membrane filter segment will undergo significant development from 2023 to 2032. Membrane filters play a pivotal role in TFF systems, facilitating the separation and concentration of biomolecules. This demand is driven by the expanding applications in biopharmaceuticals, biotechnology, and environmental sectors. As membrane filters are becoming a critical factor in ensuring efficient and precise biomolecule processing, their contribution to the tangential flow filtration market size continues to grow.
The contract research organizations and contract manufacturing organizations segment will register a commendable CAGR from 2023 to 2032. These entities require efficient and versatile purification methods for biopharmaceutical production and research. TFF's ability to separate and concentrate biomolecules with precision has made it indispensable in these sectors, aligning with their need for high-quality, scalable processes. This growing demand supports the TFF's significance in supporting the biopharmaceutical industry's expanding outsourcing requirements.
Europe tangential flow filtration market will showcase an appreciable CAGR from 2023 to 2032. This uptick is attributed to the region's robust biopharmaceutical industry and the increasing emphasis on biotechnology research and production.
For instance, in September 2023, according to insight from researchers at the University of London, Lentiviral vectors (LVs), employed for cell transfection to induce gene expression, exhibit a remarkable ability to endure shear rates that are twice the norm while sustaining equivalent productivity levels. In assessing shear forces during diafiltration, scientists employed an ultra-scale-down (USD) mimic of tangential flow filtration (TFF). TFF's ability to enhance process efficiency and product quality has made it a vital component in these sectors. Its adoption continues to grow as Europe remains at the forefront of innovative biopharmaceutical and biotechnology developments.